Merck (MRK), NewLink Genetics (NLNK) Phase 3 Trial of Investigational Ebola Vaccine Initiated in Sierra Leone
Tweet Send to a Friend
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (NASDAQ: NLNK), confirmed today ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
